Literature DB >> 20656012

Glucocorticoid dysregulation of natural killer cell function through epigenetic modification.

Karen Krukowski1, Justin Eddy, Kelly Loster Kosik, Teresa Konley, Linda Witek Janusek, Herbert L Mathews.   

Abstract

It is well-established that psychological distress reduces natural killer cell activity (NKCA) and dysregulates cytokine balance. This may be mediated by stress-induced release of glucocorticoids, which have broad effects on the immune system, including the suppression of NKCA and alteration of cytokine production. The purpose of this study was to evaluate epigenetic mechanisms that may underlie the effect of glucocorticoids on NK cells, using the human NK cell line, NK92. Treatment of NK92 cells with the synthetic glucocorticoid, dexamethasone, at a concentration of 10⁻⁷M, produced a significant reduction in NKCA. Glucocorticoid inhibition was a consequence of not only a reduced capacity of the NK cells to bind to tumor targets but also a reduced production of granule constituents (perforin and granzyme B) with no detectable effect on granule exocytosis. Glucocorticoids also reduced the constitutive and the stimulated production of the cytokines, IL-6, TNF alpha and IFN gamma, and reduced the surface expression of LFA-1. Glucocorticoid treatment also reduced global histone acetylation, the acetylation of histone 4 lysine position 8, and the accessibility of the proximal promoters of perforin, interferon gamma and granzyme B. Histone acetylation was recovered by treatment of the NK cells with a histone deacetylase inhibitor, which also restored NKCA and IFN gamma production. These results demonstrate glucocorticoids to dysregulate NK cell function at least in part through an epigenetic mechanism, which reduces promoter accessibility through modification of histone acetylation status. This epigenetic modification decreases the expression of effector proteins necessary to the full functional activity of NK cells. Copyright Â
© 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20656012      PMCID: PMC2989339          DOI: 10.1016/j.bbi.2010.07.244

Source DB:  PubMed          Journal:  Brain Behav Immun        ISSN: 0889-1591            Impact factor:   7.217


  85 in total

Review 1.  Molecular mechanisms of glucocorticoid antiproliferative effects: antagonism of transcription factor activity by glucocorticoid receptor.

Authors:  Wassim Y Almawi; Ohannes K Melemedjian
Journal:  J Leukoc Biol       Date:  2002-01       Impact factor: 4.962

2.  Triamcinolone acetonide and dexamethasome suppress TNF-alpha-induced histone H4 acetylation on lysine residues 8 and 12 in mononuclear cells.

Authors:  Loukia G Tsaprouni; Kazuhiro Ito; Neville Punchard; Ian M Adcock
Journal:  Ann N Y Acad Sci       Date:  2002-11       Impact factor: 5.691

3.  Molecular characterization of the mouse involuted thymus: aberrations in expression of transcription regulators in thymocyte and epithelial compartments.

Authors:  Crystal L Ortman; Kimberly A Dittmar; Pamela L Witte; Phong T Le
Journal:  Int Immunol       Date:  2002-07       Impact factor: 4.823

4.  DNA methylation and chromatin structure regulate T cell perforin gene expression.

Authors:  Qianjin Lu; Ailing Wu; Donna Ray; Chun Deng; John Attwood; Samir Hanash; Matthew Pipkin; Mathias Lichtenheld; Bruce Richardson
Journal:  J Immunol       Date:  2003-05-15       Impact factor: 5.422

5.  Effect of promoter methylation on the regulation of IFN-gamma gene during in vitro differentiation of human peripheral blood T cells into a Th2 population.

Authors:  Shingo Yano; Paritosh Ghosh; Hitoshi Kusaba; Meredith Buchholz; Dan L Longo
Journal:  J Immunol       Date:  2003-09-01       Impact factor: 5.422

Review 6.  Opening the chromatin for transcription.

Authors:  Ya-Jun Li; Xiang-Hui Fu; De-Pei Liu; Chih-Chuan Liang
Journal:  Int J Biochem Cell Biol       Date:  2004-08       Impact factor: 5.085

7.  Mechanism of norepinephrine-mediated inhibition of human NK cytotoxic functions: inhibition of cytokine secretion, target binding, and programming for cytotoxicity.

Authors:  Xiaohu Gan; Ling Zhang; George F Solomon; Benjamin Bonavida
Journal:  Brain Behav Immun       Date:  2002-06       Impact factor: 7.217

8.  Crucial role of DNA methylation in determination of clonally distributed killer cell Ig-like receptor expression patterns in NK cells.

Authors:  Simeon Santourlidis; Hans-Ingo Trompeter; Sandra Weinhold; Britta Eisermann; Klaus L Meyer; Peter Wernet; Markus Uhrberg
Journal:  J Immunol       Date:  2002-10-15       Impact factor: 5.422

9.  Defective glucocorticoid receptor nuclear translocation and altered histone acetylation patterns in glucocorticoid-resistant patients.

Authors:  John G Matthews; Kazuhiro Ito; Peter J Barnes; Ian M Adcock
Journal:  J Allergy Clin Immunol       Date:  2004-06       Impact factor: 10.793

10.  Tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis is an important endogenous mechanism for resistance to liver metastases in murine renal cancer.

Authors:  Naoko Seki; Yoshihiro Hayakawa; Alan D Brooks; John Wine; Robert H Wiltrout; Hideo Yagita; Jane E Tanner; Mark J Smyth; Thomas J Sayers
Journal:  Cancer Res       Date:  2003-01-01       Impact factor: 12.701

View more
  24 in total

1.  Chronic shift-lag alters the circadian clock of NK cells and promotes lung cancer growth in rats.

Authors:  Ryan W Logan; Changqing Zhang; Sengottuvelan Murugan; Stephanie O'Connell; Dale Levitt; Alan M Rosenwasser; Dipak K Sarkar
Journal:  J Immunol       Date:  2012-02-03       Impact factor: 5.422

2.  Acute exercise during hemodialysis prevents the decrease in natural killer cells in patients with chronic kidney disease: a pilot study.

Authors:  Maria Isabel Fuhro; Gilson P Dorneles; Francini P Andrade; Pedro R T Romão; Alessandra Peres; Mariane B Monteiro
Journal:  Int Urol Nephrol       Date:  2017-11-13       Impact factor: 2.370

3.  Chromatin organization as an indicator of glucocorticoid induced natural killer cell dysfunction.

Authors:  Michael S Misale; Linda Witek Janusek; Dina Tell; Herbert L Mathews
Journal:  Brain Behav Immun       Date:  2017-09-12       Impact factor: 7.217

Review 4.  Epigenetics and social context: implications for disparity in cardiovascular disease.

Authors:  Karen L Saban; Herbert L Mathews; Holli A DeVon; Linda W Janusek
Journal:  Aging Dis       Date:  2014-10-01       Impact factor: 6.745

Review 5.  Epigenetics and psychoneuroimmunology: mechanisms and models.

Authors:  Herbert L Mathews; Linda Witek Janusek
Journal:  Brain Behav Immun       Date:  2010-09-09       Impact factor: 7.217

6.  Excess maternal glucocorticoids in response to in utero undernutrition inhibit offspring angiogenesis.

Authors:  Omid Khorram; Reza Ghazi; Tsai-Der Chuang; Guang Han; Joshua Naghi; Youping Ni; William J Pearce
Journal:  Reprod Sci       Date:  2013-10-23       Impact factor: 3.060

7.  Epigenetic patterns associated with the immune dysregulation that accompanies psychosocial distress.

Authors:  Herbert L Mathews; Teresa Konley; Kelly Loster Kosik; Karen Krukowski; Justin Eddy; Kevin Albuquerque; Linda Witek Janusek
Journal:  Brain Behav Immun       Date:  2010-12-10       Impact factor: 7.217

8.  Glucocorticoid receptor mediated suppression of natural killer cell activity: identification of associated deacetylase and corepressor molecules.

Authors:  Kristin A Bush; Karen Krukowski; Justin L Eddy; Linda Witek Janusek; Herbert L Mathews
Journal:  Cell Immunol       Date:  2012-03-21       Impact factor: 4.868

9.  Impact of brief exercise on peripheral blood NK cell gene and microRNA expression in young adults.

Authors:  Shlomit Radom-Aizik; Frank Zaldivar; Fadia Haddad; Dan M Cooper
Journal:  J Appl Physiol (1985)       Date:  2013-01-03

10.  Comparison of methylprednisolone plus prednisolone with prednisolone alone as initial treatment in adult-onset minimal change disease: a retrospective cohort study.

Authors:  Maki Shinzawa; Ryohei Yamamoto; Yasuyuki Nagasawa; Susumu Oseto; Daisuke Mori; Kodo Tomida; Terumasa Hayashi; Masaaki Izumi; Megumu Fukunaga; Atsushi Yamauchi; Yoshiharu Tsubakihara; Yoshitaka Isaka
Journal:  Clin J Am Soc Nephrol       Date:  2014-04-10       Impact factor: 8.237

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.